Skip to main content

Putting the brakes on immune reactions

Helper T cells may play a dual role in the immune system, both encouraging and suppressing the process by which B cells mature.

Identifying the spark of desire in fruit flies

In Drosophila’s neural circuitry for courtship, researchers discover a configuration that enables a male fruit fly to be persistent, yet flexible in his pursuit of a female.

Purnell Choppin, pioneering virologist, has died

Purnell Choppin, a physician, virologist, and scientific administrator who performed pioneering research on viruses at The Rockefeller University and later exerted a powerful influence on biomedical research as president of the Howard Hughes Medical Institute, has died at the age of 91.

Scientists discover a new class of neurons for remembering faces

Our brains have sensory cells, which process the faces that we see, and memory cells dedicated to storing data from person encounters. But until now, a hybrid neuron capable of linking vision to memory—and explaining how we recall familiar faces—remained elusive.

Robert G. Roeder named the 2021 Kyoto Prize laureate in basic sciences

Roeder, a pioneer in the field of gene regulation and expression, is being honored for revealing the molecular mechanisms of transcriptional regulation.

Convocation 2021 caps a year like no other

For Rockefeller’s class of 2021, it has been a year with both challenges and accomplishments.

Toward the first drug to treat a rare, lethal liver cancer

After scouring more than 5,000 compounds, scientists have identified several new classes of therapeutics that may help treat fibrolamellar carcinoma.

>

A missing antibody molecule may indicate when dengue will become deadly

The antibody's altered structure helps explain an enduring mystery of dengue—why only a fraction of those infected will develop severe disease.

How CRISPR promotes antibiotic resistance in bacteria

Whenever a cell uses CRISPR to defend itself, there's a chance of mutations creeping into its genetic code. Some of these mutations are harmless; others kill the cell. But fortuitous mutations can occasionally render major human pathogens, such as Staphylococcus aureus, antibiotic resistant.

Rockefeller leads an international ranking of research impact

According to this year’s CWTS Leiden Ranking of over 1200 universities from 69 countries, Rockefeller has the highest proportion of frequently cited scientific publications.

>

Vaccines charge up natural immunity against SARS-CoV-2

Vaccination enhances antibodies in people who have had COVID, likely giving them protection even from the new variants.

New findings to boost IVF success rates

New research casts doubt on a genetic test used to screen would-be embryos for IVF implantation. The findings suggests that these embryos can develop into healthy babies regardless of whether or not they’ve been flagged as defective by the test.

Scientists release error-free genomes of 25 animals—with another 70,000 coming up

Scientists have launched an ambitious effort to produce high-quality reference genomes for all vertebrate species, from mammals to birds and reptiles. The result could be discoveries with implications for animal conservation as well as human health and disease.

A case for simplifying gene nomenclature across different organisms

Scientists call it oxytocin in humans, isotocin in fish, mesotocin in birds, and valitocin in sharks. But according to a new study, it’s all the same hormone—and high time we settled on just one name.


New Caspary exhibit honors 58 Rockefeller award winners, past and present

Redesigning the exhibit provided an opportunity to consider how to best honor and commemorate Rockefeller award winners. Discussions with university leadership and an ad-hoc faculty committee steered the process and led to a broadening of the criteria for inclusion.

Evolutionary biologist and ornithologist Richard Prum receives the 2021 Lewis Thomas Prize

The author of The Evolution of Beauty was presented with Rockefeller’s science writing award, which honors scientists as inspirational authors.

Study of “breakthrough” cases suggests COVID testing may be here to stay

Two new cases helped scientists confirm what many have come to suspect: that people can get infected by SARS-CoV-2 variants even after successful vaccination. The findings suggest continued testing may be needed to prevent future outbreaks in a post-vaccine world. <...

Inside the protein channel that keeps bacteria alive

A novel method for studying how one crucial membrane protein functions may pave the way for a new kind of broad-spectrum antibiotic.

Brain disease transmitted by tick bites may be treatable

The virus that causes tick-borne encephalitis appears to trick the immune system, misdirecting it into producing inferior antibodies. But new research shows some people produce more potent antibodies, providing hope for treatment.

Immunologist Katharine Hsu is named director of the Tri-Institutional M.D.-Ph.D. program

The joint program between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center will be lead by Hsu, an accomplished physician-scientist who specializes in immunology research and treatment of blood cancers.

Paul Cohen, expert on fat, is promoted to associate professor

Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.

Immunologist Daniel Mucida promoted to professor

A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.

Mary Jeanne Kreek, pioneer in studies of addiction, has died

Kreek conducted landmark studies that led to the establishment of methadone as a treatment for heroin addiction. Her work not only yielded new treatments for addiction disorders, but also influenced societal attitudes toward them. She was 84.

Paula Volent is named chief investment officer

The university has named its next vice president and chief investment officer. Volent, who for decades oversaw investments at Bowdoin College, will assume stewardship of Rockefeller's endowment in August.

>

How one patient’s rare mutation helped solve a mycobacterial mystery

The discovery may explain why some patients suffer more severe reactions than others—putting us one step closer to understanding how our DNA influences our susceptibility to a wide range of infectious diseases.

Financial crashes, pandemics, Texas snow: How math could predict "black swan" events

Statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences, according to a new study.

An old antibiotic may combat drug-resistant tuberculosis

Drug-resistant strains of tuberculosis bacteria affect half a million people a year. A compound first discovered in the 1980s may be able to help.

Why male mosquitoes leave humans alone

Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 

This fish is about to flip 

An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens.

Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19

The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.